MedTrace Logo

Decision Making for the Management the Symptoms in Adults of Heart Failure

NCT03549169 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2021-07-02

No results posted yet for this study

Summary

Introduction. Heart failure (HF) is the most prevailing chronic illness in the world. In Colombia, high morbidity and mortality rates because of HF are registered, as well as a significant burden of symptoms, frequent hospitalizations, poor quality of life, significant consumption of health resources and early mortality. It is necessary to propose novel strategies that can change the current picture.

Objective: determine the efficacy of an intervention centered in decision taking for the handling of symptoms in adults with HF who live in the department of Cordoba, Colombia.

Hypothesis

Primary hypothesis: the intervention Decision taking for the handling of symptoms in adults with HF: 1) Increases self-care.

Secondary hypothesis: 1) reduces clinical events: emergency care and hospitalizations, 3) Improves quality of life related to health.

Conditions

Interventions

BEHAVIORAL

TOMAS

Intervention focused on decision making for the management of symptoms aimed at adults with heart failure.

BEHAVIORAL

Regular attention

Regular attention focused on education for therapeutic adherence

Sponsors & Collaborators

  • Universidad Nacional de Colombia

    lead OTHER

Principal Investigators

  • EUGENIA HERRERA GUERRA, NURSE · Universidad Nacional de Colombia

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-04
Primary Completion
2018-12-31
Completion
2019-03-30

Countries

  • Colombia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03549169 on ClinicalTrials.gov